To investigate at the population level the impact of BRCA1/BRCA2 gene alterations in male breast cancer, we analyzed a population-based series of 25 male breast cancer cases from Florence, Central Italy. We combined mutational screening with the study of germ-line allele transcript levels and of tumor-associated losses of heterozygosity. Screening by protein truncation test and single-strand conformational polymorphism assay, followed by sequencing, revealed 4 pathogenetic mutations (4 of 25 = 16%; 95% confidence interval, 5-37%), 1 in BRCA1 and 3 in BRCA2, including mutations recurring in Central Italy (BRCA1 3345delAG and BRCA2 6696delTC). The a priori probability of carrying a mutation, estimated using BRCAPRO software, showed a good agr...
BACKGROUND: Breast cancer is an extremely complex disease, characterized by a progressive multist...
Abstract Background Mutations in BRCA1 and BRCA2 (BRCA1/2) genes are associated with an increased ri...
Mutations in BRCA1 and BRCA2 show different expressivity with respect to cancer risk, and allelic he...
BACKGROUND: Breast cancer in men is an infrequent occurrence, accounting for approximately 1% of all...
et al.Male breast cancer (MBC) is a rare disease that represents <1 % of all breast cancers (BCs). W...
BACKGROUND: Male breast cancer (MBC) is a rare disease and little is known about its aetiology. Germ...
Protein truncation test (PTT) and single-strand conformation polymorphism (SSCP) assay were used to ...
BACKGROUND.Factors that are predictive of carrying BRCA1 and BRCA2 germline mutations in patients wi...
Background\ud BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male b...
Background: BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male bre...
The heritable defects of BRCA1 and BRCA2 genes have been shown to predispose to breast and ovarian c...
International audienceMale breast cancer (MBC) is a rare and scarcely investigated disease. The stro...
Breast cancer is a rare disease in men, affecting less than 0.1% of the male population. Two heritab...
BACKGROUND: Germline mutations in the BRCA1 and BRCA2 tumour-suppressor genes predispose to early-on...
BackgroundBRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male breas...
BACKGROUND: Breast cancer is an extremely complex disease, characterized by a progressive multist...
Abstract Background Mutations in BRCA1 and BRCA2 (BRCA1/2) genes are associated with an increased ri...
Mutations in BRCA1 and BRCA2 show different expressivity with respect to cancer risk, and allelic he...
BACKGROUND: Breast cancer in men is an infrequent occurrence, accounting for approximately 1% of all...
et al.Male breast cancer (MBC) is a rare disease that represents <1 % of all breast cancers (BCs). W...
BACKGROUND: Male breast cancer (MBC) is a rare disease and little is known about its aetiology. Germ...
Protein truncation test (PTT) and single-strand conformation polymorphism (SSCP) assay were used to ...
BACKGROUND.Factors that are predictive of carrying BRCA1 and BRCA2 germline mutations in patients wi...
Background\ud BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male b...
Background: BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male bre...
The heritable defects of BRCA1 and BRCA2 genes have been shown to predispose to breast and ovarian c...
International audienceMale breast cancer (MBC) is a rare and scarcely investigated disease. The stro...
Breast cancer is a rare disease in men, affecting less than 0.1% of the male population. Two heritab...
BACKGROUND: Germline mutations in the BRCA1 and BRCA2 tumour-suppressor genes predispose to early-on...
BackgroundBRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male breas...
BACKGROUND: Breast cancer is an extremely complex disease, characterized by a progressive multist...
Abstract Background Mutations in BRCA1 and BRCA2 (BRCA1/2) genes are associated with an increased ri...
Mutations in BRCA1 and BRCA2 show different expressivity with respect to cancer risk, and allelic he...